Chairs: E. Iljazovic, BH - V. Kesic, RS
The course on gynaecological tumours has been designed for pathologists, gynecological oncologists and medical oncologists of the Eastern Europe and Balkan Region, with the aim to provide an update on the State of-the art diagnostics as well as an overview of the latest advances in the field of pathology.
The programme will offer educational lectures covering updates on the diagnosis and treatment of both early and advanced gynaecological cancers. Moreover, spotlight lectures will cover specific issues related to particular situations such as diagnostic dillemas in most challenging cases. Biological potential, questionable invasion or type of tumor as well as gynaecological cancer in young or pregnant women will be discussed.
Practical training will be offered in the frame of „tips and tricks“ sessions in a mode of case presentations, prepared and presented by participants and discussed with the faculty.
• Update on the latest advances in diagnostic procedures
• Improve practical skills in solving diagnostic dilemas/problems and setting the best diagnosis for gynaecological cancer patients
• Update on the latest advances and on the state-of-the-art treatment options
• Debate on controversies and challenges in gynaecological cancer diagnostics and treatment
• Learn about the management of specific situations
• Gyneacological cancer pathology
• Update on standard and new diagnostic and treatment options for gynecological cancer
• Patohistological diagnosis and treatment of gynaecological cancer - closer than ever
|The Course is endorsed by|
S. Carinelli, European Institute of Oncology, Milan, IT
X. Matias-Guiu, Oncological Pathology, Lleida, IRBLleida, ES
E. Iljazovic, University Clinical Center Tuzla, Tuzla, BH
V. Kesic, University of Belgrade, Medical School, Clinic for Obstetrics and Gynecology, Clinical Center of Serbia, Belgrade, RS
S. Lax, Pathology Institute, LKH Graz Süd-West, Graz, AT
S. Milenkovic, Institute for Pathology, Clinic for Obstetrics and Gynecology, Clinical Center of Serbia, Belgrade, RS
F. Peccatori, European School of Oncology, Milan, IT and Bellinzona, CH and European Institute of Oncology, Milan, IT
C. Sessa, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Tomic, Clinical Institute of Pathology KBC Split, Split, HR
Dolores Knupfer and Laura Richetti
European School of Oncology - Bellinzona Office
Piazza Indipendenza 2
CH 6500 Bellinzona - Switzerland
Tel: +41 91 820 0952
Fax: +41 91 820 0953
Email: email@example.com or firstname.lastname@example.org
CME ACCREDITATION AND CERTIFICATE
The course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
The programme has been granted 9 European CME credits (ECMEC). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.
|Application deadline:||31 January 2020|
|Save event date:||26 May 2020|
|Early registration by:||insert the date|
|Late registration by:||insert the date|
|Onsite registration from:||insert the date|
Admittance to the course is by competitive application. The successful applicants are granted free registration and full board. Non-local particpants will be offered accommodation in Tuzla for the period 26-28 May 2020. Travel will be covered by the participants.
Applications made as a team from the same institute i.e. (at least two members: pathologist and surgeon, pathologist and medical oncologist, pathologist and radiotherapist etc) to promote multidiciplinarity are welcome.
Full participation is compulsory throughout the course for all participants.
The course will be taught entirely in English and fluency in English is necessary for admission.
Priority will be given to candidates practicing in Eastern Europe and Balkan region countries.
HOW TO APPLY
Interested candidates should apply online (at the top of this page) providing:
• Letter describing motivation for attending the course - please mention here if you are participating with a team member and add their name
• Short CV – complete template provided
• Supporting letter from Head of Department/Mentor
• Abstract with proposed presentation of a pathological case relating to one of the main themes of the course:
The abstract should be presented in the form of a grand-round discussion or brief case presentation and describe:
• Diagnostic considerations
• Outcome (follow-up)
• Up to three questions that the author proposes for discussion by the faculty and participants
ATTENDANCE TO THE COURSE IS BY APPLICATION ONLY
APPLICATION DEADLINE: 31 JANUARY 2020
Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, and Abstract template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.
• Download HERE your Abstract template
• Download HERE your CV template
|8:30||Welcome address and general introduction|
C. Sessa, CH
|9:00||Diagnosis of microinvasive cervical cancer
• Challenge for colposcopist (V. Kesic, RS)
• Challenge for pathologist (S. Milenkovic, RS)
|9:30||Cervical or endometrial adenocarcinoma
E. Iljazovic, BH
|10:00||Cervical adenocarcinoma: skipping the diagnosis
E. Iljazovic, BH
|10:30||Fertility preservation in early cervical cancer: to whom it should be offered
• A brief overview of fertility sparing options (F. Peccatori, IT)
• Pathological indications for fertility sparing surgery (S. Lax, AT)
|11:30||Management of locally advanced cervical cancer
C. Sessa, CH
|12:00||Tips and tricks: Selected cases presented by participants and discussed with the faculty|
|14:30||Risk factors and pathogenesis of endometrial cancer in young women
V. Kesic, RS
|15:00||Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimen
X. Matias-Guiu, ES
|15:30||The role of Pathology in conservative management of atypical hyperplasia and early endometrial cancer
• View of clinician (V. Kesic, RS)
• View of pathologist (S. Lax, AT)
|16:00||Risk groups of endometrial cancer - does pathology influence the treatment?
X. Matias-Guiu, ES
|17:00||Tips and tricks: Selected cases presented by participants and discussed with the faculty|
|19:00||Glass with the experts|
|8:30||Borderline tumors: a never ending challenge
• View of clinician (F. Peccatori, IT)
• View of pathologist (S. Carinelli, IT)
|9:00||Tumor type: challenge of morphology
S. Tomic, HR
|9:30||Role of immunohistochemistry in daily practice: take the best
S. Carinelli, IT
|10:00||Management of ovarian cancer: challenge and future directions?
C. Sessa, CH
|11:00||Tips and tricks: Selected cases presented by participants and discussed with the faculty|
|12:30||Summary of the course|
|13:00||Buffet lunch and farewell|